Merrimack Pharmaceuticals (NASDAQ:MACK)

CAPS Rating: 3 out of 5

Recs

0
Player Avatar stemcells2011 (86.52) Submitted: 1/25/2013 1:52:52 PM : Outperform Start Price: $6.15 MACK Score: -34.06

Good news soon hopefully

Featured Broker Partners


Advertisement